This course on prescribing practices and management of chronic pain and substance use disorder is an intensive 2 ½ day course designed for physicians, dentists, nurse practitioners, physician assistants, and other clinicians in all specialties, who need or wish to increase their knowledge and ability to effectively prescribe and control medications while reducing the risk for abuse.
This course covers topics such as choosing medications, proper dosing, chronic pain diagnosis, prescribing and treatment, improper medication orders, and common bases for actions by regulatory agencies relating to medications. For a complete list of this program’s content, see below.
This course is approved by the California Medical Board as meeting the coursework requirements of physician probation.
Research indicates that up to one third of the disciplinary actions taken by Medical Boards are related to physician misprescribing practices. Learn proper prescribing practices and how best to document prescriptions for controlled substances. Learn to avoid common pitfalls including: inappropriate dispensing of medications from physician’s offices, prescribing large amounts of narcotics at frequent intervals, or prescribing to family members, friends, or a person with a known history of substance abuse.
This course has been developed to enhance the physician’s ability to effectively prescribe controlled medications, while minimizing their misuse whenever possible.
Up to 21 CME Hours (19 CME Hours in Lecture; 2 CME hours for the Pre-course) – 2 ½ day program
At the conclusion of this activity, participants should be able to:
1. Identify and prevent the common causes of prescribing-related patient injury;
2. Integrate satisfaction of patients and their families with medication treatment;
3. Recognize and protect patients’ legal rights such as informed consent relating to medications;
4. Recognize and comply with clinicians’ legal responsibilities relating to medications;
5. Integrate supervision by physicians of mid-level practitioners who prescribe or monitor medication therapy; and
6. Illustrate cooperation among members of the health care team relating to medications.
Day 1 & Day 2: 8:00 AM – 6 PM PST
Day 3: 9:00 AM – 12:30 PM PST
WILM Ed is a California Medical Board approved provider for Prescribing Practices
Until further notice, this course will be held online via Zoom. Attendees will be expected to have access to a camera and microphone.
$1,749. Organizations sponsoring multiple registrants should call (650) 212-4904 to discuss reduced tuition fees that may apply.
COURSE OBJECTIVES
At the conclusion of the course, attendees should be able to:
1. Identify and prevent the common causes of prescribing-related patient injury.
2. Integrate satisfaction of patients and families with medication treatment.
3. Recognize and protect patients’ legal rights such as informed consent relating to medications.
4. Recognize and comply with clinicians’ legal responsibilities relating to medications.
5. Integrate supervision by physicians of mid-level practitioners who prescribe or monitor medication therapy.
6. Illustrate cooperation among members of the health care team relating to medications.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the join provider-ship of the University of California, Irvine School of Medicine and the Western Institute of Legal Medicine. The University of California, Irvine School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of California, Irvine School of Medicine designates this live and enduring materials activity for a maximum of 21 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The University of California, Irvine School of Medicine Continuing Medical Education Department has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.
The statements and opinions contained in this program are solely those of the individual authors and contributors and not of the WILM Programs. The appearance of the advertisements is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The content of this presentation and publication may contain discussion of off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. The WILM Programs disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the presentation or advertisements.
